Iacobucci I, Mullighan CG. Genetic basis of acute lymphoblastic leukemia. J Clin Oncol. 2017. https://doi.org/10.1200/JCO.2016.70.7836.

Article  PubMed  PubMed Central  Google Scholar 

Paul S, Kantarjian H, Jabbour EJ. Adult acute lymphoblastic leukemia. Mayo Clin Proc. 2016. https://doi.org/10.1016/j.mayocp.2016.09.010.

Article  PubMed  Google Scholar 

Jabbour E, O’Brien S, Konopleva M, Kantarjian H. New insights into the pathophysiology and therapy of adult acute lymphoblastic leukemia. Cancer. 2015. https://doi.org/10.1002/cncr.29383.

Article  PubMed  Google Scholar 

Mar BG, Bullinger LB, McLean KM, Grauman PV, Harris MH, Stevenson K, et al. Mutations in epigenetic regulators including SETD2 are gained during relapse in paediatric acute lymphoblastic leukaemia. Nat Commun. 2014. https://doi.org/10.1038/ncomms4469.

Article  PubMed  Google Scholar 

Ruden M, Puri N. Novel anticancer therapeutics targeting telomerase. Cancer Treat Rev. 2013. https://doi.org/10.1016/j.ctrv.2012.06.007.

Article  PubMed  Google Scholar 

Dong X, Liu A, Zer C, Feng J, Zhen Z, Yang M, Zhong L. siRNA inhibition of telomerase enhances the anti-cancer effect of doxorubicin in breast cancer cells. BMC Cancer. 2009. https://doi.org/10.1186/1471-2407-9-133.

Article  PubMed  PubMed Central  Google Scholar 

Plasschaert SLA, Kamps WA, Vellenga E, de Vries EGE, de Bont ESJM. Prognosis in childhood and adult acute lymphoblastic leukaemia: a question of maturation? Cancer Treat Rev. 2004. https://doi.org/10.1016/S0305-7372(03)00140-3.

Article  PubMed  Google Scholar 

Gomez DE, Armando RG, Farina HG, Menna PL, Cerrudo CS, Ghiringhelli PD, Alonso DF. Telomere structure and telomerase in health and disease. Int J Oncol. 2012. https://doi.org/10.3892/ijo.2012.1611.

Article  PubMed  PubMed Central  Google Scholar 

Fernandes SG, Gala K, Khattar E. Telomerase inhibitor MST-312 and quercetin synergistically inhibit cancer cell proliferation by promoting DNA damage. Transl Oncol. 2023. https://doi.org/10.1016/j.tranon.2022.101569.

Article  PubMed  Google Scholar 

Ghafouri-Fard S, Khoshbakht T, Hussen BM, Dong P, Gassler N, Taheri M, Baniahmad A, Dilmaghani NA. A review on the role of cyclin dependent kinases in cancers. Cancer Cell Int. 2022. https://doi.org/10.1186/s12935-022-02747-z.

Article  PubMed  Google Scholar 

Zuehlke AD, Beebe K, Neckers L, Prince T. Regulation and function of the human HSP90AA1 gene. Gene. 2015. https://doi.org/10.1016/j.gene.2015.06.018.

Article  PubMed  Google Scholar 

Lee JW, Cho B. Prognostic factors and treatment of pediatric acute lymphoblastic leukemia. Korean J Pediatr. 2017. https://doi.org/10.3345/kjp.2017.60.5.129.

Article  PubMed  Google Scholar 

Gharehchahi F, Zare F, Rafie Dehbidi G, Yousefi Z, Pourpirali S, Tamaddon G. 2021 The Effect of Epigallocatechin gallate on Cross-talk Between Autophagy and Apoptosis in NALM-6 Cell Line. 2021 https://doi.org/10.21203/rs.3.rs-1111288/v1

Dorman HJD, Deans SG. Antimicrobial agents from plants: antibacterial activity of plant volatile oils. J Appl Microbiol. 2000. https://doi.org/10.1046/j.1365-2672.2000.00969.x.

Article  PubMed  Google Scholar 

Ghasemimehr N, Farsinejad A, Mirzaee Khalilabadi R, Yazdani Z, Fatemi A. The telomerase inhibitor MST-312 synergistically enhances the apoptotic effect of doxorubicin in pre-B acute lymphoblastic leukemia cells. Biomed Pharmacother. 2018. https://doi.org/10.1016/j.biopha.2018.07.140.

Article  PubMed  Google Scholar 

Fernandes SG, Gala K, Khattar E. Telomerase inhibitor MST-312 and quercetin synergistically inhibit cancer cell proliferation by promoting DNA damage. Transl Oncol. 2023. https://doi.org/10.1016/j.tranon.2022.101569.

Article  PubMed  Google Scholar 

Sameni S, Viswanathan R, Quan GY, Martinez-Lopez W, Hande P. Telomerase inhibition by MST-312 sensitises breast cancer cells to anti-cancer properties of Plumbagin. bioRxiv. 2023. https://doi.org/10.1101/2023.05.29.542688.

Article  Google Scholar 

Niu M, Zhang B, Li L, Su Z, Pu W, Zhao C, et al. Targeting HSP90 inhibits proliferation and induces apoptosis through AKT1/ERK pathway in lung cancer. Front Pharmacol. 2022. https://doi.org/10.3389/fphar.2021.724192.

Article  PubMed  PubMed Central  Google Scholar 

Faruq O, Zhao D, Shrestha M, Vecchione A, Zacksenhaus E, Chang H. Targeting an MDM2/MYC axis to overcome drug resistance in multiple myeloma. Cancers. 2022. https://doi.org/10.3390/cancers14061592.

Article  PubMed  PubMed Central  Google Scholar 

Ameri Z, Ghiasi S, Farsinejad A, Hassanshahi G, Ehsan M, Fatemi A. Telomerase inhibitor MST-312 induces apoptosis of multiple myeloma cells and down-regulation of anti-apoptotic, proliferative and inflammatory genes. Life Sci. 2019. https://doi.org/10.1016/j.lfs.2019.04.060.

Article  PubMed  Google Scholar 

Nag S, Qin J, Srivenugopal KS, Wang M, Zhang R. The MDM2-p53 pathway revisited. J Biomed Res. 2013. https://doi.org/10.7555/JBR.27.20130030.

Article  PubMed  Google Scholar 

Fu H, Wang C, Yang D, Wei Z, Xu J, Hu Z, et al. Curcumin regulates proliferation, autophagy, and apoptosis in gastric cancer cells by affecting PI3K and P53 signaling. J Cell Physiol. 2018. https://doi.org/10.1002/jcp.26190.

Article  PubMed  Google Scholar